CLINICAL_TRIALS
trial_result
· 2013-02-20
Clinical Trial Update: Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis [Phase 1]
Summary
Pfizer completed a Phase 1 multiple-dose escalation study in medically stable subjects with psoriasis; results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Pfizer | Conditions: Psoriasis, Immunomodulation | Phase 1 | Status: COMPLETED | Results posted: 2013-02-20